Coronary Artery Disease Clinical Trial
Official title:
Interval Training in Cardiac Rehabilitation: Effects on Cardiorespiratory Fitness and Platelet Function - A Randomized Controlled Trial
The purpose of this study is to determine whether high intensity interval training (INT) is more effective in suppressing platelet reactivity than continuous, moderate intensity training (CONT) in patients undergoing cardiac rehabilitation after percutaneous coronary intervention.
Background: Platelets play an important role in cardiovascular disease: First, they promote
the development of atherosclerotic lesions, and second, platelets form vessel occluding
thrombi on top of (ruptured) lesions, ultimately leading to thrombotic events like myocardial
infarctions (MCI). Whereas acute, strenuous exercise causes platelet activation and
transiently increases the risk for MCIs, long-term chronic exercise training results in a
clear reduction of both platelet activation and MCI incidence.
Exercise training plays a key role in cardiac rehabilitation, since improvements in
cardiorespiratory fitness (CRF) are associated with decreased mortality in these patients.
With respect to CRF improvements, high-intensity interval training has been demonstrated to
be more effective than moderate-intensity continuous exercise. However, the beneficial effect
of high-intensity interval training on platelet function in patients with cardiovascular
disease has never been investigated.
Scientific question: The aim of this study is to determine the effect of interval training in
cardiac rehabilitation on platelet function.
Hypotheses: Cardiac rehabilitation with interval training components (INT) reduces
1. platelet activation and platelet reactivity at physical rest
2. changes of platelet activation and -reactivity induced by acute, strenuous exercise to a
greater extent than cardiac rehabilitation consisting exclusively of moderate-intensity
continuous exercise training (CONT).
Work program: 80 patients at the beginning of phase II cardiac rehabilitation will be
randomly assigned to an interval group or to a control group. In both groups, patients will
exercise 4x / week for 12 weeks. At the beginning, after 6 weeks and at the end an exercise
test will be carried out. Blood will be taken before (platelet function at rest) and
immediately after each exercise test (platelet function after acute, strenuous exercise).
Basal platelet activation as well as platelet responsiveness towards a platelet agonist
(platelet reactivity) will be analyzed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |